Kuwahara, A., Yamamori, M., Fujita, M., Okuno, T., Tamura, T., Kadoyama, K., . . . Sakaeda, T. (2010). TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma. BioMed Central.
শিকাগো স্টাইলে সাইটেশনKuwahara, Akiko, Motohiro Yamamori, Megumi Fujita, Tatsuya Okuno, Takao Tamura, Kaori Kadoyama, Noboru Okamura, Tsutomu Nakamura, এবং Toshiyuki Sakaeda. TNFRSF1B A1466G Genotype Is Predictive of Clinical Efficacy After Treatment With a Definitive 5-fluorouracil/cisplatin-based Chemoradiotherapy in Japanese Patients With Esophageal Squamous Cell Carcinoma. BioMed Central, 2010.
এমএলএ সাইটেশনKuwahara, Akiko, et al. TNFRSF1B A1466G Genotype Is Predictive of Clinical Efficacy After Treatment With a Definitive 5-fluorouracil/cisplatin-based Chemoradiotherapy in Japanese Patients With Esophageal Squamous Cell Carcinoma. BioMed Central, 2010.